Cargando…
Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
Patients with muscle-infiltrating bladder cancer (MIBC) present a high risk of postoperative recurrence and death from metastatic urothelial cancer despite surgical resection. Before the use of peri-operative chemotherapy, about half (52%) of patients undergoing radical cystectomy had had a relapse...
Autores principales: | Zucali, Paolo Andrea, Cordua, Nadia, D'Antonio, Federica, Borea, Federica, Perrino, Matteo, De Vincenzo, Fabio, Santoro, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609911/ https://www.ncbi.nlm.nih.gov/pubmed/33194654 http://dx.doi.org/10.3389/fonc.2020.568279 |
Ejemplares similares
-
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
por: Perrino, Matteo, et al.
Publicado: (2023) -
Systemic treatments for thymic tumors: a narrative review
por: Zucali, Paolo Andrea, et al.
Publicado: (2021) -
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
por: Borea, Federica, et al.
Publicado: (2023) -
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma
por: Tufano, Antonio, et al.
Publicado: (2022) -
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Giugliano, Federica, et al.
Publicado: (2022)